Vitalograph Enhances Global Reach with Strategic Acquisition
Vitalograph has made a significant leap by acquiring Morgan Scientific, a respected leader in pulmonary function testing (PFT) software. This acquisition represents a crucial moment for Vitalograph as it seeks to strengthen its ability to meet the rising global need for respiratory diagnostic solutions. With this strategic decision, the company aims to enhance its commercial presence in the U.S. and drive innovation in advanced PFT solutions.
Strengthening an Established Partnership
Frank Keane, CEO of Vitalograph, shared his excitement about the partnership with Morgan Scientific, describing this acquisition as a natural next step for both companies. He highlighted that their combined expertise will enable them to deliver exceptional diagnostic solutions aimed at better understanding lung health.
The Role of Morgan Scientific's Expertise
Morgan Scientific has earned a strong reputation for its customer-focused software, particularly in the area of advanced PFT systems. Its leading software, ComPAS2, plays a vital role in the VitaloPFT Series, showcasing Vitalograph’s commitment to advancing pulmonary function testing. Additionally, Morgan Scientific has served as a key distributor for Vitalograph's PFT solutions throughout the United States.
Exciting Collaborative Innovations Ahead
Looking back on their collaborative experiences, Keane remarked on the valuable knowledge gained in developing the VitaloPFT Series. This shared effort has established a solid foundation based on mutual respect and recognition of the strengths each company brings. The acquisition of Morgan Scientific is poised to provide significant benefits, allowing for continued enhancement of Vitalograph's extensive PFT offerings to meet global customer needs.
Commitment to Integrity and Innovation
As a family-owned business, Vitalograph places great importance on the values exemplified by Morgan Scientific, including integrity, quality, and innovation. Gareth Morgan, the son of Morgan Scientific's founder, expressed a strong belief in Vitalograph’s ability to sustain and build upon their legacy of customer service and innovation.
Aspiring for Growth in Respiratory Diagnostics
This acquisition will play a crucial role in significantly accelerating Vitalograph's planned expansion of its respiratory diagnostic offerings worldwide. The company has embarked on an ambitious growth strategy with the aim of tripling its respiratory diagnostics business by 2026. This initiative reflects a firm dedication to advancing respiratory healthcare solutions while prioritizing quality and reliability.
The Importance of This Milestone
This acquisition aligns with Vitalograph’s celebration of its 50th anniversary, marking a moment of pride in the company's journey of innovation and growth in Ireland. Not only does this strategic acquisition demonstrate Vitalograph’s commitment to enhancing lung health through innovative solutions, but it also shows its prepared response to the evolving demands of the healthcare sector.
About Vitalograph
Founded in 1963, Vitalograph has developed into a leading global provider of respiratory diagnostic solutions and clinical drug trial services. With decades of experience, the company offers a wide range of accurate and dependable respiratory diagnostic solutions that empower healthcare professionals around the world. This commitment to excellence is evident in its dedication to enhancing patient care and health outcomes.
Frequently Asked Questions
What led Vitalograph to acquire Morgan Scientific?
The acquisition was motivated by a shared objective to improve their capacity to provide advanced respiratory diagnostic solutions that meet growing global needs.
How will this acquisition benefit customers?
Customers can look forward to greater access to innovative pulmonary function testing solutions, improved service delivery, and an expanded array of products resulting from the combined skills of both companies.
What does ComPAS2 refer to?
ComPAS2 is the flagship software developed by Morgan Scientific that supports the VitaloPFT Series, which is crucial for delivering advanced pulmonary function testing solutions.
What does Vitalograph plan to do following the acquisition?
Vitalograph is working to grow its respiratory diagnostics business significantly and enhance its product offerings to deliver comprehensive solutions for respiratory healthcare worldwide.
Who should be contacted regarding media inquiries?
Media inquiries can be directed to Edwina Gore from Gore Communications or Laura Colleran from Vitalograph, who are the primary contacts for information and support related to the acquisition and upcoming initiatives.
